IFF lays out five hydration need states for GLP-1 users, and Innova counts a 190% rise in launches carrying GLP-1-friendly claims.
Recap by typeshit. Full story at BeverageDaily.
A short Facebook share with no context on who used the peptides, where it happened or what followed.
Benzinga notes a 1.89% after-hours gain for Lilly stock, with Novo Nordisk also tagged. No further detail on what drove the move.
Mikhail Varshavski tells Fox News why protein matters, especially for GLP-1 users. He has a paid partnership with Quest Nutrition.
2:07:50
A live Q&A session covering GLP-1 drugs including Zepbound, Wegovy and Foundayo, with the host taking questions from viewers.
Fewer than 15% of 102 surveyed US doctors could recall recent obesity drug news unprompted, but most who knew retatrutide's TRIUMPH-2 data said it would sway prescribing.
Researchers report a hazard ratio of 0.717 versus lifestyle changes in TriNetX records, while stressing the observational data can't prove the drug prevents cancer.
Loading…